Biphasic modulation of NMDA-induced responses in pyramidal cells of the medial prefrontal cortex by Y-931, a potential atypical antipsychotic drug

Synapse

Volumn 41, Issue 4, 2001, Pages 294-300

  Jardemark, Kent E ^a   Ai, Jinglu ^a,b   Ninan, Ipe ^a   Wang, Rex Y ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

AMPA; Antipsychotic drugs; Medial prefrontal cortex; NMDA; PCP; Y 931

Indexed keywords

8 FLUORO 12 (4 METHYLPIPERAZIN 1 YL) 6H [1]BENZOTHIENO[2,3 B][1,5] BENZODIAZEPINE MALEATE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; UNCLASSIFIED DRUG; Y 931;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROSTIMULATION; EVOKED RESPONSE; EXCITATORY POSTSYNAPTIC POTENTIAL; LIMBIC CORTEX; NEGATIVE SYNDROME; NEUROTRANSMISSION; NONHUMAN; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SCHIZOPHRENIA;

2-AMINO-5-PHOSPHONOVALERATE; 6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; MEMBRANE POTENTIALS; N-METHYLASPARTATE; ORGAN CULTURE TECHNIQUES; PATCH-CLAMP TECHNIQUES; PHENCYCLIDINE; PIPERAZINES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS;

EID: 0035885490     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1086     Document Type: Article

References (46)

1. NMDA-induced response in pyramidal neurons of the rat medial prefrontal cortex slices consists of NMDA and non-NMDA components
2. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate -receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro
3. Clozapine, but not haloperidol, prevents the functional hyperactivity of NMDA receptors in rat cortical neurons induced by subchronic administration of phencyclidine
4. Clozapine and haloperidol modulate NMDA- and non-NMDA receptor mediated neurotransmission in rat prefrontal cortical neurons in vitro
5. 2A receptor agonist DOB on NMDA-evoked responses in pyramidal neurons of the rat medial prefrontal cortex
6. 2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex
7. Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response
8. 1A dopamine receptor from G(s) protein
9. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
10. Molecular and physiological diversity of cortical nonpyramidal cells
11. Intrinsic firing patterns of diverse neocortical neurons
12. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviours
13. Actions of clozapine and haloperidol on the extracellular levels of excitatory amino acids in the prefrontal cortex and striatum of conscious rats
14. A glutamatergic hypothesis of schizophrenia: Rationale for pharmacology with glycine
15. Creation of a constitutively activated state of the 5-hydroxytryptamine-2A receptor by site-directed mutagenesis: Inverse agonist activity of antipsychotic drugs
16. Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity
17. Optimal voltage clamping with single microelectrodes
18. Antipsychotics with inverse agonist activity at the dopamine D3 receptor
19. Voltage-clamp analysis of muscarinic excitation in hippocampal neurons
20. Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine-2C receptors
21. Metabotropic glutamate receptor agonist-induced hyperpolarization in rat basolateral amygdala neurons: Receptor characterization, second messengers and ion channels
22. Physiological and morphological identification of somatostatin- or vasoactive intestinal polypeptide-containing cells among GABAergic cell subtypes in rat frontal cortex
23. Failure of haloperidol to block the effects of phencyclidine an dizocilpine on prepulse inhibition of startle
24. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia
25. Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists
26. Ketamine activates psychosis and alters limbic blood flow in schizophrenia
27. Biphasic modulatory action of the selective sigma receptor ligand SR31742A on N-methyl-D-aspartate-induced neuronal responses in the frontal cortex
28. Voltage clamp analysis of cholinergic action in the hippocampus
29. Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: A study with ketamine
30. Comparative electrophysiology of pyramidal and sparsely spiny stellate neurons of the neocortex
31. Y-931, a novel antipsychotic with potential property to ameliorate NMDA receptor-hypofunction (NRH). I. Receptorial and pharmacological profile in comparison with clozapine and haloperidol
32. The atypical antipsychotic. Profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist in rats
33. Glutamate receptor dysfunction and schizophrenia
34. Activation of postsynaptic metabotropic glutamate receptors by trans-ACPD hyperpolarizes neurons of the basolateral amygdala
35. Somatostatin inhibition of hippocampal CA1 pyramidal neurons: Mediation by arachidonic acid and its metabolites
36. Y-931, a novel antipsychotic with potential property to ameliorate NMDA receptor-hypofunction (NRH). II. Further characterization in comparison with clozapine and haloperidol
37. Seroquel restores sensorimotor gating in phencyclidine-treated rats
38. Schizophrenia and glutamatergic transmission
39. Actions of 5-HT on neurons of rat cingulated cortex
40. Glutamate: A new target in schizophrenia
41. 2A receptor antagonist and a potential atypical antipsychotic drug, facilitates induction of long-term potentiation in area CA1 of the rat hippocampal slice
42. M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice
43. Facilitation of NMDA transmission by olanzapine
44. Single-electrode voltage clamp analysis of the N-methyl-D-aspartate component of synaptic responses in neocortical slices from children with intractable epilepsy
45. Brain region effects of clozapine on amino acid and monoamine transmission
46. Electrophysiological and morphological properties of layers V-VI principal pyramidal cells in rat prefrontal cortex in vitro